Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the trial is to evaluate the efficacy and safety of orally administered CG5503 PR (base) at doses of 100-250 mg twice daily in subjects with moderate to severe chronic pain from OA of the knee
Inclusion criteria
- Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee